[Atrophic polychondritis and aseptic meningoencephalitis].
Sost
G
G
Noyon
V
V
Cador
B
B
Jégo
P
P
Grosbois
B
B
D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001706:Biopsy; D003221:Confusion / Q000209:etiology; D004359:Drug Therapy, Combination; D004569:Electroencephalography; D005260:Female; D006212:Hallucinations / Q000209:etiology; D006801:Humans; D008279:Magnetic Resonance Imaging; D008582:Meningitis, Aseptic / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D008590:Meningoencephalitis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D011081:Polychondritis, Relapsing / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D011241:Prednisone / Q000627:therapeutic use; D013129:Spinal Puncture
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D011241:Prednisone
Polychondrite atrophiante et méningoencéphalite aseptique.